Medical Device User Fee Stabilization Act of 2005

The Medical Device User Fee Stabilization Act of 2005 (Public Law 109-43) adjusted the fees that medical device manufacturers pay to the Food and Drug Administration (FDA) to fund the review and approval process for new products. The law set fixed fee amounts for 2006 and 2007 to provide financial predictability for the industry and expanded the definition of a "small business" to allow more companies to qualify for reduced fees or waivers. Additionally, it established new labeling requirements for reprocessed single-use medical devices to ensure the manufacturer is clearly identified for safety and tracking purposes.

For the average citizen, these changes were designed to ensure the FDA remained adequately funded to review the safety and effectiveness of medical technology without placing an undue financial burden on smaller innovators. By stabilizing these fees and clarifying labeling for reprocessed equipment, the law aimed to maintain a steady flow of new medical devices to the healthcare market while enhancing patient safety through better device identification.